Navigation Links
Dyadic International To Present At World Biofuels Markets
Date:3/4/2013

JUPITER, Fla., March 4, 2013 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries, announced today that its President and CEO, Mark Emalfarb , will be making a presentation at the World Biofuels Markets exhibition at the Beurs-World Trade Center in Rotterdam, The Netherlands during its Advanced Biofuels Session: Transformative Technologies, at 4:00 p.m. local time on March 13, 2013.

(Logo:  http://photos.prnewswire.com/prnh/20110621/CL06708LOGO )

All attendees of the World Biofuels Markets are welcome to visit Dyadic's stand located at Booth #E506 where Dyadic's leading scientists will be available to discuss specific applications of Dyadic's AlternaFuel® CMAX™ biofuels enzymes.

The World Biofuels Markets is Europe's largest biofuels congress and exhibition and one of the industry's premier events, supporting the world's development and search for alternative energy sources.

About Dyadic

Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries. Please visit Dyadic's website at www.dyadic.com.

Cautionary Statement for Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.


'/>"/>
SOURCE Dyadic International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Dyadic International To Announce Year-End 2012 Financial Results And Host Conference Call On Thursday, March 7, 2013
2. Dyadic International Upgraded By OTC Markets To "Current Information" Tier
3. 12th U.S. Patent Issued To Dyadic International
4. Dyadic International Reports 2012 Third Quarter Financial Results
5. Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
6. Dyadic International to Announce Second Quarter 2012 Financial Results and Host Conference Call on Monday, August 13, 2012
7. Dyadic Demonstrates Industry-leading Biofuels Enzyme Performance
8. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
9. Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
10. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
11. BioHealth Innovation, Inc. President & CEO Richard Bendis to Present at SXSW 2013 & 2013 BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... ZeptoMetrix ... falciparum culture panels with standard concentrations of histidine rich protein 2 (HRP2). ... range of concentrations from six different malaria strains, are intended for use by ...
(Date:1/24/2017)... ... January 23, 2017 , ... Oklahoma City based Sigma ... client for the firm’s PERFEQTA software and legacy product QC Manager 2.0. , ... dynamic team at CJBC and thrilled that they have decided to implement PERFEQTA and ...
(Date:1/24/2017)... Jan. 23, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: ... an underwriting agreement with Rodman & Renshaw, a unit ... sole book running manager and representative of several underwriters, under ... firm commitment basis a minimum of 2,105,264 shares of ... purchase a minimum of 1,052,632 shares of common stock ...
(Date:1/23/2017)... Atlas Genetics Ltd., the ultra-rapid Point-Of-Care (POC) molecular ... raising $35 million from a syndicate including all Series C ... ... Genetics io® system has been completed with the successful CE ... 2016.  This new Series D equity issue will finance the ...
Breaking Biology Technology:
(Date:12/16/2016)... MIAMI , Dec. 16, 2016   ... intuitive Identity management products and solutions and a ... announced today that it is offering seamless, integrated ... Edam security entrance products. The solutions provide IdentyTech,s ... to secure their facilities from crime and theft. ...
(Date:12/15/2016)... VANCOUVER, Canada and BADEN-BADEN, Germany ... Solutions, a leading global financial services provider, today announced an ... in passive behavioural biometrics, to join forces. The partnership will ... fraud mitigation strategies in compliance with local data protection regulation. ... In ...
(Date:12/15/2016)... , Dec. 15, 2016 ... driving experience, health wellness and wellbeing (HWW), ... one in three new passenger vehicles begin ... recognition, gesture recognition, heart beat monitoring, brain ... monitoring, facial monitoring, and pulse detection. These ...
Breaking Biology News(10 mins):